OKYO vs. CW
OKYO (OKYO Pharma Ltd ADR) and CW (Curtiss-Wright Corporation) are both stocks. OKYO operates in Biotechnology (Healthcare), while CW operates in Specialty Industrial Machinery (Industrials). Over the past 3 years, OKYO returned 16.64%/yr vs 59.55%/yr for CW. At a 0.11 correlation, their price movements are largely independent.
Performance
OKYO vs. CW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OKYO achieves a -18.36% return, which is significantly lower than CW's 37.01% return.
OKYO
- 1D
- 0.60%
- 1M
- 11.18%
- 6M
- -38.77%
- YTD
- -18.36%
- 1Y
- -39.86%
- 3Y*
- 16.64%
- 5Y*
- —
- 10Y*
- —
CW
- 1D
- -0.65%
- 1M
- -0.39%
- 6M
- 24.82%
- YTD
- 37.01%
- 1Y
- 59.73%
- 3Y*
- 59.55%
- 5Y*
- 44.52%
- 10Y*
- 24.86%
OKYO vs. CW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
OKYO OKYO Pharma Ltd ADR | -18.36% | 80.02% | -35.03% | -7.33% | -57.56% |
CW Curtiss-Wright Corporation | 37.01% | 55.66% | 59.73% | 33.98% | 21.87% |
Correlation
The correlation between OKYO and CW is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since May 17, 2022 | 0.11 |
The correlation between OKYO and CW shifts across timeframes, from 0.11 (all time) to 0.23 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
OKYO:
$64.84M
CW:
$27.88B
OKYO:
-$0.20
CW:
$13.69
OKYO:
$0.00
CW:
$3.61B
OKYO:
-$6.82K
CW:
$1.34B
OKYO:
-$9.59M
CW:
$745.31M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OKYO vs. CW — Risk / Return Rank
OKYO
CW
OKYO vs. CW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for OKYO Pharma Ltd ADR (OKYO) and Curtiss-Wright Corporation (CW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| OKYO | CW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.30 | ||
| Sortino ratioReturn per unit of downside risk | -2.76 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 1.30 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 4.60 | -5.35 |
| Martin ratioReturn relative to average drawdown | -1.03 | 13.21 | -14.24 |
Loading charts...
Drawdowns
OKYO vs. CW - Drawdown Comparison
The maximum OKYO drawdown since its inception was -79.15%, which is greater than CW's maximum drawdown of -59.19%. Use the drawdown chart below to compare losses from any high point for OKYO and CW.
Loading charts...
Drawdown Indicators
| OKYO | CW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.15% | -59.19% | -19.96% |
Max Drawdown (1Y)Largest decline over 1 year | -54.43% | -12.97% | -41.46% |
Max Drawdown (3Y)Largest decline over 3 years | -69.14% | -27.21% | -41.93% |
Max Drawdown (5Y)Largest decline over 5 years | — | -27.21% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -48.73% | — |
Current DrawdownCurrent decline from peak | -62.44% | -4.79% | -57.65% |
Average DrawdownAverage peak-to-trough decline | -60.90% | -13.87% | -47.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.79% | 4.50% | +35.29% |
Volatility
OKYO vs. CW - Volatility Comparison
OKYO Pharma Ltd ADR (OKYO) has a higher volatility of 14.08% compared to Curtiss-Wright Corporation (CW) at 9.68%. This indicates that OKYO's price experiences larger fluctuations and is considered to be riskier than CW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OKYO | CW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.08% | 9.68% | +4.40% |
Volatility (6M)Calculated over the trailing 6-month period | 51.83% | 25.84% | +25.99% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.17% | 33.47% | +45.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 104.02% | 27.92% | +76.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 104.02% | 30.30% | +73.72% |
Dividends
OKYO vs. CW - Dividend Comparison
OKYO has not paid dividends to shareholders, while CW's dividend yield for the trailing twelve months is around 0.13%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CW Curtiss-Wright Corporation | 0.13% | 0.17% | 0.23% | 0.35% | 0.45% | 0.51% | 0.58% | 0.47% | 0.59% | 0.46% | 0.53% | 0.76% |
OKYO OKYO Pharma Ltd ADR | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
OKYO vs. CW - Financials Comparison
This section allows you to compare key financial metrics between OKYO Pharma Ltd ADR and Curtiss-Wright Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
OKYO and CW have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OKYO has higher volatility (14.08%) compared to CW (9.68%). In terms of maximum drawdown, OKYO dropped -79.15% vs CW's -59.19%.
CW currently has the higher Sharpe Ratio (1.78 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OKYO and CW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer